ARTICLE | Emerging Company Profile
Nabla: Using AI to ‘auto-complete’ biologics design
Harvard spinout working toward push-button designs for challenging targets
January 14, 2026 8:08 AM UTC
While Nabla is one of many companies applying AI to protein design, it is focused on a persistent bottleneck in the field: making biologics manufacturable without losing their therapeutic relevance
Nabla Bio Inc. was founded in 2020 by Surge Biswas, CEO, and Frances Anastassacos, president, who developed the platform in George Church’s lab at Harvard University...